Patent · US Active

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof

US10323257B2 · kind B2 · utility

5Cited by
0References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 13, 2017
Grant dateJun 18, 2019
Priority date
Expiry dateDec 13, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/203
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors and polyvalent vaccines comprising the recombinant HVT vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.